<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">FLUMAZENIL <img border="0" src="../images/pr.gif"/></span><br/>(flu-ma'ze-nil)<br/><span class="topboxtradename">Mazicon <img border="0" src="../images/maple.gif"/>, </span><span class="topboxtradename">Romazicon<br/></span><b>Classifications:</b> <span class="classification">central nervous system agent</span>; <span class="classification">benzodiazepine antagonist</span><br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>0.1 mg/mL injection</p>
<h1><a name="action">Actions</a></h1>
<p>Antagonizes the effects of benzodiazepine on the CNS, including sedation, impairment of recall, and psychomotor impairment.
         Does not reverse the effects of opioids.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Reverses the action of a benzodiazepine.</p>
<h1><a name="uses">Uses</a></h1>
<p>Complete or partial reversal of sedation induced by benzodiazepine for anesthesia or diagnostic or therapeutic procedures
         and through overdose.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Seizure disorders, alcohol intoxication, hepatic encephalopathy, facilitation of weaning from mechanical ventilation.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to flumazenil or to benzodiazepines; patients given a benzodiazepine for control of a life-threatening condition;
         patients showing signs of cyclic antidepressant overdose; seizure-prone individuals during labor and delivery. Effects on
         children are not established.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Hepatic function impairment, older adults, pregnancy (category C), lactation, intensive care patients, head injury, drug-
         and alcohol-dependent patients, and physical dependence upon benzodiazepines.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Reversal of Sedation</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 0.2 mg over 15 sec, may repeat 0.2 mg q60sec for 4 additional doses or a cumulative dose of 1 mg<br/><br/><span class="indicationtitle">Benzodiazepine Overdose</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IV</span> 0.2 mg over 30 sec, if no response after 30 sec, then 0.3 mg over 30 sec, may repeat with 0.5 mg q60sec (max: cumulative dose
               of 3 mg)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1>
<table cellpadding="4" cellspacing="0" class="ivbox" width="100%">
<tr>
<td><span class="ivtitle">Intravenous</span><p><span class="routemethod">PREPARE:</span> <span class="methodtype">Direct:</span> May give undiluted or diluted. If diluted use D5W, Lactated Ringer's, NS.  
               </p>
<p><span class="routemethod">ADMINISTER:</span> <span class="methodtype">Direct:</span>   Ensure patency of IV before administration of flumazenil, since extravasation will cause local irritation. Give through an IV that is freely flowing into a large vein. Give each 0.2 mg dose in small quantities over 15 sec. Each 0.2
                  mg dose should be given in small quantities over 15 sec. Repeat at 60 sec intervals (see Route &amp; Dosage). Do not give as a
                  bolus dose. In high-risk patients, slow the rate to intervals of 610 min to provide the smallest effective dose. Give repeat doses at 20 min intervals if resedation occurs (max: 1 mg given at a rate of 0.2 mg/min, not to exceed 3 mg in
                  any 1-h period). Use all diluted solutions within 24 h of dilution. 
               </p>
</td>
</tr>
</table>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Emotional lability, headache, <span class="speceff-common">dizziness,</span> agitation, <span class="speceff-common">resedation,</span> seizures, blurred vision. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea, vomiting,</span> hiccups. <span class="typehead">Other:</span> Shivering, pain at injection site, hypoventilation. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> May antagonize effects of <b>zaleplon,</b>
<b>zolpidem;</b> may cause convulsions or arrhythmias with <span class="classification">tricyclic antidepressants</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead"> Onset:</span>  15 min. <span class="typehead">Peak:</span> 610 min. <span class="typehead">Duration:</span> 24 h. <span class="typehead">Metabolism:</span> Metabolized in the liver to inactive metabolites. <span class="typehead">Elimination:</span> 9095% excreted in urine, 510% in feces within 72 h. <span class="typehead">Half-Life:</span> 54 min. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Monitor respiratory status carefully until risk of resedation is unlikely (up to 120 min). Drug may not fully reverse benzodiazepine-induced
            ventilatory insufficiency.
         </li>
<li>Monitor carefully for seizures and take appropriate precautions.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Do not drive or engage in potentially hazardous activities until at least 1824 h after discharge following a procedure.</li>
<li>Do not ingest alcohol or nonprescription drugs for 1824 h after flumazenil is administered or if the effects of the
            benzodiazepine persist.
         </li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>